Mtbvac phase 1B/2A randomized, double-blind, active-controlled, safety, immunogenicity, and dose-escalation study in adults with and without latent tuberculosis infection in south africa
Ended Cooperative Agreement Awarded Last action
- Award ID
- U01AI131861
- Recipient
-
International Aids Vaccine Initiative Inc. UEI ZEJBC8JQM3P5
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $512,683
Award facts
- Assistance listing
- 93.855 Allergy and Infectious Diseases Research
- Completion date
- Originally
- Place of performance
- South Africa
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | -$114,061 | |
| Amendment | -$43,812 | |
| Amendment | -$43,812 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $131,886 | |
| Amendment | $210,000 | |
| Amendment | -$210,000 | |
| Amendment | -$342,000 | |
| Amendment | $372,482 | |
| Amendment | $342,000 | |
| Original award | $210,000 |
Show all 20
Quick answers
Who received award U01AI131861?
U01AI131861 was awarded to International Aids Vaccine Initiative Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on August 18, 2017.
How much is award U01AI131861 worth?
$512,683 has been obligated on U01AI131861.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award